Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Platinum-sensitive Relapsed Ovarian Cancer × fluzoparib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Breast Neoplasms 2 SCLC, Extensive Stage 1 Platinum-sensitive Relapsed Ovarian Cancer 1 Glioblastoma 1 Female Breast Cancer Patients 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

fluzoparib 1 Paclitaxel 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06446206 2024-06-06

Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer

The First Hospital of Jilin University

Phase 2 Not yet recruiting

Platinum-sensitive Relapsed Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡